Literature DB >> 28100521

Perioperative α-receptor blockade in phaeochromocytoma surgery: an observational case series.

H Groeben1, B J Nottebaum2, P F Alesina3, A Traut4, H P Neumann5, M K Walz3.   

Abstract

BACKGROUND: Mortality associated with surgery for phaeochromocytoma has dramatically decreased over the last decades. Many factors contributed to the dramatic decline of the mortality rate, and the influence of an α-receptor blockade is unclear and has never been tested in a randomized trial. We evaluated intraoperative haemodynamic conditions and the incidence of complications in patients with and without α-receptor blockade undergoing surgery for catecholamine producing tumours.
METHODS: Haemodynamic conditions and perioperative complications were assessed in 110 patients with (B) and 166 without (N) α-receptor blockade. Data were analysed as a consecutive case series of 303 cases and subsequently via propensity score matching, and presented as mean and confidence interval (CI).
RESULTS: No difference in maximal intraoperative systolic arterial pressures (B = 178 mm Hg (CI 169-187) vs N = 185 mm Hg (CI 177-193; P = 0.2542) and hypertensive episodes above 250 mm Hg were found (P = 0.7474) for the closed case series. No major complications occurred. Propensity score matching (75 pairs) revealed a significant difference of 17 mm Hg in maximal intraoperative systolic bp for these selected pairs (P = 0.024).
CONCLUSIONS: Only a slight difference in mean maximal systolic arterial pressure was detected between patients with or without an α-receptor blockade. There was no difference in the incidence of excessive hypertensive episodes between groups and no major complications occurred. The basis for the general recommendation of perioperative α- receptor blockade for phaeochromocytoma surgery demands further study.
© The Author 2017. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  doxazosin; paraganglioma; phaeochromocytoma; phenoxybenzamine

Mesh:

Substances:

Year:  2017        PMID: 28100521     DOI: 10.1093/bja/aew392

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  29 in total

1.  Pheochromocytoma surgery without systematic preoperative pharmacological preparation: insights from a referral tertiary center experience.

Authors:  Cyrille Buisset; Carole Guerin; Pierre-Julien Cungi; Mickael Gardette; Nunzia-Cinzia Paladino; David Taïeb; Thomas Cuny; Frederic Castinetti; Frederic Sebag
Journal:  Surg Endosc       Date:  2020-02-18       Impact factor: 4.584

Review 2.  Challenges of training in adrenal surgery.

Authors:  Oliver Gimm; Quan-Yang Duh
Journal:  Gland Surg       Date:  2019-07

Review 3.  Is there any role for minimally invasive surgery in NET?

Authors:  M Thomaschewski; H Neeff; T Keck; H P H Neumann; T Strate; E von Dobschuetz
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 4.  Morphology and etiology of pheochromocytoma.

Authors:  H P H Neumann; K W Schmid; C Eng
Journal:  Pathologe       Date:  2019-12       Impact factor: 1.011

5.  A NECESSITY, NOT A SECOND THOUGHT: PRE-OPERATIVE ALPHA-ADRENOCEPTOR BLOCKADE IN PHEOCHROMOCYTOMA PATIENTS.

Authors:  Jenn Rachelle U Santos; Katherine I Wolf; Karel Pacak
Journal:  Endocr Pract       Date:  2019-02       Impact factor: 3.443

6.  Minimally Invasive Surgery (MIS) in Children and Adolescents with Pheochromocytomas and Retroperitoneal Paragangliomas: Experiences in 42 Patients.

Authors:  Martin K Walz; Laura D Iova; Judith Deimel; Hartmut P H Neumann; Birke Bausch; Stefan Zschiedrich; Harald Groeben; Pier F Alesina
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

Review 7.  Hypertension in Pheochromocytoma and Paraganglioma: Evaluation and Management in Pediatric Patients.

Authors:  Meredith L Seamon; Ikuyo Yamaguchi
Journal:  Curr Hypertens Rep       Date:  2021-05-27       Impact factor: 5.369

8.  WHY TAKE THE RISK? WE ONLY LIVE ONCE: THE DANGERS ASSOCIATED WITH NEGLECTING A PRE-OPERATIVE ALPHA ADRENOCEPTOR BLOCKADE IN PHEOCHROMOCYTOMA PATIENTS.

Authors:  Katherine I Wolf; Jenn Rachelle U Santos; Karel Pacak
Journal:  Endocr Pract       Date:  2018-10-05       Impact factor: 3.443

Review 9.  Pheochromocytoma/paraganglioma: recent updates in genetics, biochemistry, immunohistochemistry, metabolomics, imaging and therapeutic options.

Authors:  Karren Antonio; Ma Margarita Noreen Valdez; Leilani Mercado-Asis; David Taïeb; Karel Pacak
Journal:  Gland Surg       Date:  2020-02

Review 10.  Surgical approach to patients with pheochromocytoma.

Authors:  Dhaval Patel
Journal:  Gland Surg       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.